SCHEMBL4433351

SCHEMBL4433351

Fc1cccc(-c2nc3c(F)cccc3cc2CCNc2ncnc3[nH]cnc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 8/20 0.41
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 2/20 0.39
HTT P42858 2/20 0.39
JAK2 O60674 2/20 0.37
JAK3 P52333 2/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
PRKD3 O94806 1/20 0.37
PAK4 O96013 1/20 0.37
ABL1 P00519 1/20 0.37
LCK P06239 1/20 0.37
CSF1R P07333 1/20 0.37
RET P07949 1/20 0.37
PDGFRB P09619 1/20 0.37
FGFR1 P11362 1/20 0.37
PRKACA P17612 1/20 0.37
FLT1 P17948 1/20 0.37
LTK P29376 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16799113 0.93 LMNA (0.39) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4434824 0.92 LMNA (0.42) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4435767 0.91 MAP4K4 (0.40) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4435698 0.89 HTT (0.37) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4434206 0.88 HTT (0.38) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4436004 0.88 HTT (0.54) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4433753 0.86 MAPK1 (0.37) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4433726 0.85 HTT (0.37) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL4436316 0.85 MAP4K4 (0.39) MAP4K4LMNASMN1; SMN2MAPK1HTT
SCHEMBL248722 0.84 MAP4K4 (0.39) MAP4K4LMNASMN1; SMN2MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137186-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2009-12-30 EP disclosed
WO-2008118468-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2008-10-02 WO disclosed